What is Cenegenics?
Cenegenics operates at the intersection of biotechnology, metabolic science, and personalized medicine. The company provides a comprehensive Performance Health Age Management solution, utilizing sophisticated diagnostic data and proprietary technology to deliver tailored health interventions. By focusing on cognitive, physical, and metabolic markers, Cenegenics distinguishes itself from traditional wellness providers through a clinical, science-first approach. Its market position is anchored in the delivery of measurable health outcomes, effectively bridging the gap between preventative medicine and peak human performance. As the longevity industry continues to attract institutional interest, Cenegenics remains a key player in the professionalization of age management services.
How much funding has Cenegenics raised?
Cenegenics has raised a total of $13M across 2 funding rounds:
Debt
$1M
Private Equity
$12M
Debt (2020): $1M with participation from PPP
Private Equity (2022): $12M led by Best Life Brands
Key Investors in Cenegenics
Best Life Brands
Best Life Brands is a holding company that includes premier franchised providers of in-home care, franchised senior placement organizations, and an estate sale franchise. Best Life Brands was founded in 2018 and is headquartered in Michigan.
PPP
Public-Private Partnership
What's next for Cenegenics?
With the recent influx of capital, Cenegenics is expected to prioritize the expansion of its technological infrastructure and the scaling of its clinical service delivery models. The strategic focus will likely center on enhancing the integration of metabolic data into its patient-facing platforms, thereby increasing the precision of its health management protocols. Furthermore, the company is well-positioned to explore new market segments, potentially leveraging its partnership with established holding entities to broaden its reach. As the firm moves into this next phase of growth, the emphasis will remain on maintaining clinical rigor while scaling operations to meet the increasing global demand for longevity-focused health solutions.
See full Cenegenics company page
